MP-PEG8-VA-PABC-PBD Dimer is a drug-linker conjugates for ADC which is used in the treatment of several cancers. PBD Dimer is a DNA alkylating which inhibits DNA replication[1].

Sulfo-PDBA-DM4 is a drug-linker conjugate for antibody-drug conjugate (ADC) applications, combining the potent tubulin inhibitor DM4 with the gluthatione-cleavable linker Sulfo-PDBA. This configuration harnesses DM4's cytotoxic potential through Sulfo-PDBA's targeted delivery mechanism.

Mal-Phe-C4-VC-PAB-MMAE is a chemical compound resulting from the conjugation of monomethyl auristatin E (MMAE), a potent tubulin inhibitor serving as a toxin payload in antibody-drug conjugates, with a Mal-Phe-C4-VC-PAB linker.

TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride (compound 9) is a drug-linker conjugate used in antibody-drug conjugates (ADCs) with high efficacy against tumors. It consists of TLR7/8 agonist 4, a potent TLR7/8 agonist, linked to the ADC linker hydroxy-PEG10-acid which can be cleaved.

GGFG-PAB-Exatecan 由有毒分子 Exatecan 和连接子 GGFG-PAB 构成，可作为合成 ADC 分子的药物-连接子偶合物使用。

Val-Cit-PABC-DOX (compound 10109) 作为一种ε-聚-L-赖氨酸基的药物偶联体，属于抗体药物偶联物 (ADC) 的活性连接部分 (drug-linker conjugate)。该化合物是通过 Val-Cit-PABC 链接 DNAtopoisomeraseI 与 topoisomeraseII 的抑制剂 Doxorubicin 来构成的。